PD-1 Inhibitor Plus G-CSF in Recurrent/Metastatic NPC With First-line Treatment Failure
Clinical trial NCT05222035 · UNKNOWN
Trial details
- NCT number
- NCT05222035
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2022-12-24
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.